Office of Technology Transfer – University of Michigan

High-Confidence Single-Molecule Detection of RNA Biomarkers

Technology #6250

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Image Gallery
Categories
Researchers
Nils Walter
Managed By
Ed Pagani
Assistant Director, Health Technologies 734-763-3558
Patent Protection
PCT Patent Application WO 2017/139354
US Patent Pending 2016-0046988
US Patent Pending
US Patent Pending

Rapid, Amplification- and Label-Free, Ultrahigh-Confidence Counting of Single RNA and Other Biomarker Molecules in Patient Samples

MicroRNAs (miRNAs) and other non-coding RNAs (ncRNAs) have recently emerged as promising diagnostic biomarkers for virtually all pathologies, including cancer, heart disease, diabetes, Alzheimer’s, and viral infection. We have developed a novel technology platform for the specific and ultra-sensitive detection of virtually any biomarker of interest through a kinetic “fingerprinting” approach called Single Molecule Recognition through Equilibrium Poisson Sampling (SiMREPS). The SiMREPS platform achieves the rapid, amplification-free counting of single label-free miRNA and ncRNA molecules, bypasses thermodynamic limits of specificity, virtually eliminates false positives, utilizes no enzymes and hence requires minimal pre-treatment of biological samples prior to biomarker detection and avoids the introduction of sampling bias. We have demonstrated the ultrahigh-confidence single-molecule detection of endogenous miRNAs in minimally treated patient samples such as blood serum and cell extracts in under 30 minutes, as well as the >500-fold discrimination against a single nucleotide polymorphism. In addition, SiMREPS can utilize its kinetic “fingerprint” to sensitively detect changes in the accessibility of a sensor RNA or DNA upon biomarker binding to detect virtually any type of secondary biomarker.